Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Depsipeptide in Metastatic Neuroendocrine Tumors

NCT00084461 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00084461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00084461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Depsipeptide in Metastatic Neuroendocrine Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2004
Completion date
Not reported
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrinoma, glucagonoma, insulinoma, metastatic gastrointestinal carcinoid tumor, pancreatic polypeptide tumor, pulmonary carcinoid tumor, recurrent gastrointestinal carcinoid tumor, recurrent islet cell carcinoma, regional gastrointestinal carcinoid tumor, somatostatinoma